-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"The new stage of big shuffle and big integration in China's pharmaceutical industry is coming, and digital transformation has become an inevitable choice for Chinese pharmaceutical enterprises to grasp the trend and seek high-quality development."
" is what McKinsey said in its 2019 article Breaking the Butterfly: The Road to Transformation for Chinese Pharmaceutical Companies.
data show that the average annual compound growth rate of sales in China's pharmaceutical market is about 10.7%, but the traditional pharmaceutical model is still the main form of the industry.
this year, experienced the baptism of the epidemic, forcing pharmaceutical companies to improve customer management, operation management and other aspects of capacity.
to accelerate the digital transformation, with a view to improving the immunity and vitality of enterprises, reduce costs, has become the consensus of the pharmaceutical industry.
, with China's support to encourage the development of the "Internet plus health care" system, as well as the two-vote system, health care reform and other policies, the process of informationization of pharmaceutical enterprises has been accelerating.
background, domestic pharmaceutical companies are beginning to realize the importance of digital transformation, some began to take the fine engineering route, and some use digital integration upstream and downstream industrial chain to enhance competitiveness.
But in the process of embracing digitalization, many pharmaceutical companies are still facing the difficulties of transformation, there are such as lack of top-level design, insufficient driving force, information system and GMP specification integration is not high, information island, IT management is weak and other issues, it is urgent to find a breakthrough method.
August 28, 2020 at 14:00, the pharmaceutical network will join forces with METTLER TOLIDO to bring a debate on "Where is the road to digital transformation of broken medicine, enterprise process improvement?" "Online keynotes.
the speech will be discussed from three sub-topics, with a view to the development of the pharmaceutical industry to point to the mystery, welcome to lock the live room.
PS: Early sign-in viewers receive a mystery package prepared jointly by Pharmaceuticals.com and METTLER TOLEDO - Please look forward to scanning the QR code above to check in.